Mori Hamada has advised JT on the sale of its pharmaceutical business and its subsidiary Torii Pharmaceutical to Shionogi.
The Mori Hamada team was led by partners Hideki Ben, Kazuhiro Kanamaru, Taichi Arai and Yusuke Takamiya, senior associates Yurika Inoue, Yuki Kawai and Kohei Shiozaki, associate Yu Furuhashi.
Period
May, 2025
Practices